Rivastigmine for Refractory REM Behavior Disorder in Mild Cognitive Impairment

201450 citationsJournal Article

Authors

Valerio Brunetti · Università Cattolica del Sacro Cuore

Anna Losurdo

Giacomo Della Marca · Università Cattolica del Sacro Cuore

Abstract

Our data suggest that, in MCI patients with RBD resistant to conventional therapies (muscle relaxants benzodiazepines or melatonin,) treatment with RVT may induce a reduction in the frequency of RBD episodes compared to placebo.

Topics & Keywords

Cholinesterase and Neurodegenerative Diseases Memory and Neural Mechanisms Attention Deficit Hyperactivity Disorder

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Alzheimer Research

Volume 11, Issue 3, pp. 267-273

DOI: 10.2174/1567205011666140302195648

Field-Weighted Citation Impact: 2.26